bpc 157 human studies clinical trials safety BPC-157 and the Difference Between an Evidence Gap and a Cover-Up: What the entire evidence base actually looks like, and the questions to ask next. — WellFounded What is BPC-157? | Everything

The strongest published finding is from the foundational Biochemical Pharmacology study by Neelakantan et al.: in diet-induced obese mice, daily 5-Amino-1MQ administration produced reductions in body weight, white adipose tissue mass, and adipocyte size without any significant change in food intake

BPC-157 also enhances growth hormone receptor expression in fibroblasts and promotes FAK-paxillin pathway activation critical for cellular adhesion, migration, proliferation, and survival during tissue repair processes

In cell culture and in vitro models, BPC-157 has been investigated for its interactions with the nitric oxide (NO) system, including modulation of both eNOS and iNOS pathways

ProHealth states each batch is independently tested three times by third-party labs with Certificates of Analysis published on the product page

The Chronic Patient: Perhaps more tragic is the patient who suffered a concussion months or years ago and is told they have reached a "clinical plateau." They are told their headaches, brain fog, and fatigue are permanent because their MRI is "normal." This is a false premise